Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNC105P and everolimus in metastatic clear cell renal cell carcinoma
NCT01034631Phase 2Completed
- Sponsor
- Hoosier Cancer Research Network
- Start
- Jan 2010
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of BNC105P in clear cell renal cell carcinoma (ccRCC), sponsored by Hoosier Cancer Research Network. Started Jan 2010; status: completed.
02
Drugs
BNC105P
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT01034631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034631.